These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 9289719)
1. [Circulating immune complexes as markers of Hodgkin's disease activity]. Urbaniak-Kujda D Pol Tyg Lek; 1996 May; 51(19-22):303-4. PubMed ID: 9289719 [TBL] [Abstract][Full Text] [Related]
2. [Circulating immune complexes in the serum in Hodgkin's disease]. Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679 [TBL] [Abstract][Full Text] [Related]
3. Correlation between immune complexes and prognostic factors in Hodgkin's disease. Amlot PL; Pussell B; Slaney JM; Williams BD Clin Exp Immunol; 1978 Feb; 31(2):166-73. PubMed ID: 648026 [TBL] [Abstract][Full Text] [Related]
4. [Circulating immune complexes in the serum of patients with Hodgkin's disease]. Berényi E; Kávai M; Pálkövi E; Szegedi G Orv Hetil; 1979 Jan; 120(2):79-82. PubMed ID: 760038 [No Abstract] [Full Text] [Related]
8. [Appearance of circulating immune complexes in patients with Hodgkin's disease and the etiology of this disease]. Dziewulska-Bokiniec A; Sztaba-Kania M Wiad Lek; 1992 Oct; 45(19-20):740-3. PubMed ID: 1296377 [TBL] [Abstract][Full Text] [Related]
12. [The diagnostic and prognostic significance of the level of circulating immune complexes in patients with recurrent erysipelas]. Frolov VM; Boĭchenko PK; Peresadin NA Vrach Delo; 1990 Jun; (6):116-8. PubMed ID: 2399704 [TBL] [Abstract][Full Text] [Related]
13. Role of circulating immune-complexes as prognostic indicators of lympho-reticular and mesenchymal malignancies in children. Aziz M; Dass TK; Rattan A J Trop Pediatr; 1992 Aug; 38(4):185-8. PubMed ID: 1527815 [TBL] [Abstract][Full Text] [Related]
14. Letter: Immune complexes in Hodgkin's disease. Kávai M; Berényi E; Pálkovi E; Szegedi G Lancet; 1976 Jun; 1(7971):1249. PubMed ID: 58301 [No Abstract] [Full Text] [Related]
15. The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients. Velardi A; Spinozzi F; Rambotti P; Tabilio A; Losito A; Zampi I; Cernetti C; Martelli MF; Grignani F; Davis S J Clin Oncol; 1983 Feb; 1(2):117-25. PubMed ID: 6668495 [TBL] [Abstract][Full Text] [Related]
16. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease]. Kuljić-Kapulica N Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363 [TBL] [Abstract][Full Text] [Related]
17. Reaction of immune complexes with Hodgkin's disease tissue cultures. Long JC; Dvorak AM; Quay SC; Stamatos C J Natl Cancer Inst; 1981 Jul; 67(1):3. PubMed ID: 6942193 [No Abstract] [Full Text] [Related]
18. Circulating immune complexes in Hodgkin's disease. Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278 [TBL] [Abstract][Full Text] [Related]
19. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q. Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175 [TBL] [Abstract][Full Text] [Related]
20. The predictive value of circulating immune complexes (CIC) in patients with malignant salivary gland tumors. Lotfy M; Yassin S; Ezz M Egypt Dent J; 1993 Oct; 39(4):547-8. PubMed ID: 9588121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]